2026 ICD-10-CM Diagnosis Code M33.03Juvenile dermatomyositis without myopathy
ICD-10-CM Codes›M00–M99›M30-M36›M33
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Risk Adjusts — HCC 93
- Chronic Condition
M33.03 is a billable ICD-10-CM diagnosis code for juvenile dermatomyositis without myopathy. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 545 through 547. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 15 closely related codes. Coders also document this condition as childhood type dermatomyositis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Systemic lupus erythematosus and connective tissue disorders.
For Medicare Advantage risk adjustment, M33.03 maps to CMS-HCC Category 93 (Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders) under the V28 model, adding a risk factor of about 0.617 for a community, non-dual, aged beneficiary in payment year 2026.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
M33.03 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.
Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Childhood type dermatomyositis
- Hypomyopathic juvenile dermatomyositis
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Dermatomyositis (acute) (chronic) See Also: Dermatopolymyositis;
amyopathic M33.03
without myopathy M33.03
amyopathic M33.03
without myopathy M33.03
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert M33.03 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code History & ChangesHistory
Replacement M33.03 replaces the following previously assigned code(s):
- M33.00 - Juvenile dermatomyositis, organ involvement unspecified
- M33.00 - Juvenile dermatopolymyositis, organ involvement unspecified
Questions About M33.03Overview
What is the ICD-10 code for juvenile dermatomyositis without myopathy?
The ICD-10-CM code for juvenile dermatomyositis without myopathy is M33.03 (sometimes written as M3303). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is M33.03 (Juvenile dermatomyositis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report juvenile dermatomyositis without myopathy on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does M33.03 group to?
When juvenile dermatomyositis without myopathy is the principal diagnosis on an inpatient stay, it groups to MS-DRG 545, 546, 547, with relative weights from 0.8362 to 2.4817 depending on complications. Higher weights mean higher Medicare reimbursement.
Is M33.03 a CC or MCC?
CMS lists M33.03 as a CC (complication or comorbidity) for FY 2026. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 15 closely related codes in its exclusion list.
What is the ICD-9 equivalent of M33.03?
Under the General Equivalence Mappings, juvenile dermatomyositis without myopathy converts to ICD-9-CM 710.3 (dermatomyositis). The mapping is approximate, so confirm the match fits the documentation.
What HCC is M33.03?
M33.03 (juvenile dermatomyositis without myopathy) maps to CMS-HCC Category 93 (Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders), commonly written as HCC 93, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 40 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 83.
Does M33.03 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, M33.03 adds a risk adjustment factor of about 0.617 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.288 to 0.617 depending on the payment segment). HCC 93 sits at the top of its hierarchy, so no other condition category supersedes it. See the full factor table on the HCC 93 category page.
